Eagle Pharmaceuticals Inc Net Asset Momentum
Eagle Pharmaceuticals Inc net asset momentum. Eagle Pharmaceuticals Inc (EGRX) recorded a net asset momentum of 32.4% as of December 2022, with net assets of $233.56 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Eagle Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Eagle Pharmaceuticals Inc (2012–2022)
Net asset momentum of Eagle Pharmaceuticals Inc from 2012 to 2022. This chart tracks Eagle Pharmaceuticals Inc's year-over-year net asset growth across 11 annual reporting periods from 2012 to 2022. The most recent momentum reading is +32.4%, with net assets of $233.56 Million USD as of December 2022. See EGRX net asset value for net asset value and shareholders' equity analysis.
Eagle Pharmaceuticals Inc Net Asset Momentum by Year (2012–2022)
Eagle Pharmaceuticals Inc net asset momentum by year from 2012 to 2022. The table below shows the complete annual net asset history for Eagle Pharmaceuticals Inc from 2012 to 2022, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see EGRX stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2022 | $233.56 Million | $406.16 Million | $172.60 Million | ▲ +32.4% |
| 2021 | $176.45 Million | $253.73 Million | $77.28 Million | ▼ -5.1% |
| 2020 | $186.01 Million | $253.19 Million | $67.18 Million | ▲ +3.8% |
| 2019 | $179.17 Million | $254.55 Million | $75.38 Million | ▲ +11.5% |
| 2018 | $160.76 Million | $238.60 Million | $77.84 Million | ▼ -10.3% |
| 2017 | $179.14 Million | $270.06 Million | $90.92 Million | ▲ +18.5% |
| 2016 | $151.23 Million | $213.57 Million | $62.34 Million | ▲ +67.4% |
| 2015 | $90.34 Million | $124.61 Million | $34.26 Million | ▲ +173.0% |
| 2014 | $33.10 Million | $53.41 Million | $20.32 Million | ▲ +1511.3% |
| 2013 | $2.05 Million | $18.10 Million | $16.05 Million | ▲ +117.0% |
| 2012 | $-12.10 Million | $9.44 Million | $21.54 Million | — |